Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhaoke Pharmaceutical (Guangzhou), also known as ZKGZ Biotech, is a major research and production subsidiary of Lee's Pharmaceutical Holdings. The company specializes in integrated drug development and manufacturing, particularly in oncology, dermatology, and cardiovascular health. In December 2024, the company successfully launched its in-house developed ZKGZ-003 (Adapalene and Clindamycin Hydrochloride Gel) for acne treatment. Its pipeline also includes an inhaled fentanyl aerosol for breakthrough cancer pain and several innovative candidates for solid tumors and cardiovascular conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhaoke Pharmaceutical (Guangzhou).